Skip to content

Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: a randomized multi-center phase III trial (AkNiPro2)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518182-10-00
Acronym
KKSH155
Enrollment
336
Registered
2024-10-30
Start date
2021-01-13
Completion date
2025-06-10
Last updated
2024-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acoustic schwannoma

Brief summary

Postoperative cochlear nerve function measured before discharge according to GR scale 1-3 versus GR 4-5 (binary)

Detailed description

Late postoperative cochlear nerve function measured at follow up three to six months after surgery (end of study) according to GR scale 1-3 versus GR 4-5 (binary), Postoperative deterioration of cochlear nerve function of at least one grade according to the GR scale compared with its preoperative function (binary), Late postoperative deterioration of cochlear nerve function of at least one grade according to the GR scale compared with its preoperative function measured at follow up three to six months after surgery (end of study) (binary), Change of pure-tone thresholds (PTA) and speech discrimination score (WRSmax), Comparison between GR-scores and AAOHNS-scores, Intraoperative deterioration of BAEP mean values (amplitudes and latencies), Subjective quality of life / psychosocial impairment assessed by patient’s questionnaires (HHIE, SF-12, PANQOL) before surgery and at follow up three to six months, Anatomical preservation of the cochlear nerve and preservation of wave V (BAEP), Data on the safety and side effects of the medication will be obtained. For this purpose, adverse events are recorded descriptively in both groups and evaluated. Particular attention will be paid to intra and postoperative symptomatic hypotension.

Interventions

DRUGNimotop® S
DRUG10 mg/50 ml

Sponsors

Martin-Luther-Universitaet Halle-Wittenberg
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Postoperative cochlear nerve function measured before discharge according to GR scale 1-3 versus GR 4-5 (binary)

Secondary

MeasureTime frame
Late postoperative cochlear nerve function measured at follow up three to six months after surgery (end of study) according to GR scale 1-3 versus GR 4-5 (binary), Postoperative deterioration of cochlear nerve function of at least one grade according to the GR scale compared with its preoperative function (binary), Late postoperative deterioration of cochlear nerve function of at least one grade according to the GR scale compared with its preoperative function measured at follow up three to six months after surgery (end of study) (binary), Change of pure-tone thresholds (PTA) and speech discrimination score (WRSmax), Comparison between GR-scores and AAOHNS-scores, Intraoperative deterioration of BAEP mean values (amplitudes and latencies), Subjective quality of life / psychosocial impairment assessed by patient’s questionnaires (HHIE, SF-12, PANQOL) before surgery and at follow up three to six months, Anatomical preservation of the cochlear nerve and preservation of wave V (BAEP), Data

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026